These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31496699)

  • 41. Development of Betamethasone Dipropionate-Loaded Nanostructured Lipid Carriers for Topical and Transdermal Delivery.
    Hanna PA; Ghorab MM; Gad S
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(1):26-44. PubMed ID: 30430947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
    Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
    Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N; Chakraborty S; De AK; Ghosh S; Bera T
    Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
    Shinde UA; Parmar SJ; Easwaran S
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin.
    Malgarim Cordenonsi L; Faccendini A; Catanzaro M; Bonferoni MC; Rossi S; Malavasi L; Platcheck Raffin R; Scherman Schapoval EE; Lanni C; Sandri G; Ferrari F
    Int J Pharm; 2019 Aug; 567():118487. PubMed ID: 31271813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
    Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
    Okonogi S; Riangjanapatee P
    Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment.
    Shen CY; Dai L; Shen BD; Zhou X; Bai JX; Xu H; Lv QY; Han J; Yuan HL
    Chin J Nat Med; 2015 Jun; 13(6):454-60. PubMed ID: 26073342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies.
    Elmowafy M; Shalaby K; Ali HM; Alruwaili NK; Salama A; Ibrahim MF; Akl MA; Ahmed TA
    Int J Pharm; 2019 Dec; 572():118781. PubMed ID: 31715347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion.
    Loo Ch; Basri M; Ismail R; Lau H; Tejo B; Kanthimathi M; Hassan H; Choo Y
    Int J Nanomedicine; 2013; 8():13-22. PubMed ID: 23293516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
    Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
    Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis.
    Huguet-Casquero A; Xu Y; Gainza E; Pedraz JL; Beloqui A
    Int J Pharm; 2020 Aug; 586():119515. PubMed ID: 32544520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models.
    Riaz A; Hendricks S; Elbrink K; Guy C; Maes L; Ahmed N; Kiekens F; Khan GM
    AAPS PharmSciTech; 2020 Jul; 21(5):185. PubMed ID: 32632542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.